Abstract:Metabolism of xenobiotics remains a central challenge for the discovery and development of drugs, cosmetics, nutritional supplements, and agrochemicals. Metabolic transformations are frequently related to the incidence of toxic effects that may result from the emergence of reactive species, the systemic accumulation of metabolites, or by induction of metabolic pathways. Experimental investigation of the metabolism of small organic molecules is particularly resource demanding; hence, computational methods are of considerable interest to complement experimental approaches. This review provides a broad overview of structure- and ligand-based computational methods for the prediction of xenobiotic metabolism. Current computational approaches to address xenobiotic metabolism are discussed from three major perspectives: (i) prediction of sites of metabolism (SOMs), (ii) elucidation of potential metabolites and their chemical structures, and (iii) prediction of direct and indirect effects of xenobiotics on metabolizing enzymes, where the focus is on the cytochrome P450 (CYP) superfamily of enzymes, the cardinal xenobiotics metabolizing enzymes. For each of these domains, a variety of approaches and their applications are systematically reviewed, including expert systems, data mining approaches, quantitative structure-activity relationships (QSARs), and machine learning-based methods, pharmacophore-based algorithms, shape-focused techniques, molecular interaction fields (MIFs), reactivity-focused techniques, protein-ligand docking, molecular dynamics (MD) simulations, and combinations of methods. Predictive metabolism is a developing area, and there is still enormous potential for improvement. However, it is clear that the combination of rapidly increasing amounts of available ligand- and structure-related experimental data (in particular, quantitative data) with novel and diverse simulation and modeling approaches is accelerating the development of effective tools for prediction of in vivo metabolism, which is reflected by the diverse and comprehensive data sources and methods for metabolism prediction reviewed here. This review attempts to survey the range and scope of computational methods applied to metabolism prediction and also to compare and contrast their applicability and performance.

Predicting ADME properties in silico: methods and models

Structure-ADME relationship: still a long way to go?

Structure – ADME Relationship: Still a Long Way to Go?

In silico ADME-Tox modeling: progress and prospects

The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Recent Advances On In Silico Adme Modeling

Recent Progresses in the Exploration of Machine Learning Methods As In-Silico ADME Prediction Tools

Open access in silico tools to predict the ADMET profiling of drug candidates

Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties

Validating ADME QSAR Models Using Marketed Drugs

Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery

Recent Advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: A Review

In Silico Prediction Of Adverse Drug Reactions And Toxicities Based On Structural, Biological And Clinical Data

Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms

Interpretable-ADMET: a web service for ADMET prediction and optimization based on deep neural representation

In silico ADME/tox comes of age: twenty years later

Recent advances in computational prediction of drug absorption and permeability in drug discovery.

ADME Evaluation in Drug Discovery. Part 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property‐Based Rules?

SwissADME and pkCSM Webservers Predictors: an integrated Online Platform for Accurate and Comprehensive Predictions for In Silico ADME/T Properties of Artemisinin and its Derivatives

ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints.